Shaw M. Akula

3.7k total citations
77 papers, 2.9k citations indexed

About

Shaw M. Akula is a scholar working on Oncology, Epidemiology and Molecular Biology. According to data from OpenAlex, Shaw M. Akula has authored 77 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Oncology, 31 papers in Epidemiology and 19 papers in Molecular Biology. Recurrent topics in Shaw M. Akula's work include Viral-associated cancers and disorders (34 papers), Cytomegalovirus and herpesvirus research (26 papers) and Herpesvirus Infections and Treatments (16 papers). Shaw M. Akula is often cited by papers focused on Viral-associated cancers and disorders (34 papers), Cytomegalovirus and herpesvirus research (26 papers) and Herpesvirus Infections and Treatments (16 papers). Shaw M. Akula collaborates with scholars based in United States, Italy and Poland. Shaw M. Akula's co-authors include Bala Chandran, Fuzhang Wang, James A. McCubrey, Hosni A. M. Hussein, Pramod P. Naranatt, Lia R. Walker, Ossie F. Dyson, Ling Zeng, Linda S. Steelman and Stephen L. Abrams and has published in prestigious journals such as Cell, Journal of Biological Chemistry and Blood.

In The Last Decade

Shaw M. Akula

75 papers receiving 2.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shaw M. Akula United States 28 1.3k 1.2k 819 437 402 77 2.9k
Fang Guo China 29 548 0.4× 784 0.7× 935 1.1× 599 1.4× 401 1.0× 97 2.7k
Kei Kawana Japan 37 755 0.6× 1.3k 1.1× 1.2k 1.4× 1.1k 2.5× 130 0.3× 206 4.2k
Hua Peng China 28 1.0k 0.8× 620 0.5× 1.1k 1.3× 1.7k 3.9× 305 0.8× 67 3.4k
Subburaj Ilangumaran Canada 35 1.1k 0.8× 475 0.4× 1.6k 1.9× 1.5k 3.4× 184 0.5× 101 3.6k
Susanna Chiocca Italy 34 982 0.7× 534 0.5× 2.6k 3.2× 490 1.1× 236 0.6× 93 4.0k
Dieter Kube Germany 30 1.1k 0.8× 764 0.7× 794 1.0× 1.4k 3.3× 139 0.3× 76 3.2k
Julio Gutiérrez United States 33 705 0.5× 895 0.8× 726 0.9× 910 2.1× 206 0.5× 82 2.8k
Gangqiao Zhou China 26 602 0.4× 363 0.3× 1.2k 1.5× 441 1.0× 254 0.6× 82 2.4k
Klaus Roemer Germany 32 945 0.7× 422 0.4× 2.3k 2.8× 331 0.8× 169 0.4× 83 3.7k
Bruno Sáinz Spain 39 1.7k 1.3× 1.1k 1.0× 2.0k 2.5× 964 2.2× 393 1.0× 88 4.7k

Countries citing papers authored by Shaw M. Akula

Since Specialization
Citations

This map shows the geographic impact of Shaw M. Akula's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shaw M. Akula with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shaw M. Akula more than expected).

Fields of papers citing papers by Shaw M. Akula

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shaw M. Akula. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shaw M. Akula. The network helps show where Shaw M. Akula may publish in the future.

Co-authorship network of co-authors of Shaw M. Akula

This figure shows the co-authorship network connecting the top 25 collaborators of Shaw M. Akula. A scholar is included among the top collaborators of Shaw M. Akula based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shaw M. Akula. Shaw M. Akula is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dickerson, Anne E., et al.. (2025). The miRNomics of antiretroviral therapy-induced obesity. Functional & Integrative Genomics. 25(1). 81–81.
2.
3.
Pokhrel, Lok R., et al.. (2022). Preclinical efficacy and safety of novel SNAT against SARS-CoV-2 using a hamster model. Drug Delivery and Translational Research. 12(12). 3007–3016. 7 indexed citations
4.
Abrams, Stephen L., Shaw M. Akula, Linda S. Steelman, et al.. (2021). Effects of the MDM2 inhibitor Nutlin-3a on sensitivity of pancreatic cancer cells to berberine and modified berberines in the presence and absence of WT-TP53. Advances in Biological Regulation. 83. 100840–100840. 6 indexed citations
5.
Akula, Shaw M., Stephen L. Abrams, Linda S. Steelman, et al.. (2020). Cancer therapy and treatments during COVID-19 era. Advances in Biological Regulation. 77. 100739–100739. 33 indexed citations
6.
Duda, Przemysław, Shaw M. Akula, Stephen L. Abrams, et al.. (2020). GSK-3 and miRs: Master regulators of therapeutic sensitivity of cancer cells. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1867(10). 118770–118770. 15 indexed citations
7.
Akula, Shaw M. & James A. McCubrey. (2020). Where are we with understanding of COVID-19?. Advances in Biological Regulation. 77. 100745–100745. 5 indexed citations
8.
Akula, Shaw M., Stephen L. Abrams, Linda S. Steelman, et al.. (2019). RAS/RAF/MEK/ERK, PI3K/PTEN/AKT/mTORC1 and TP53 pathways and regulatory miRs as therapeutic targets in hepatocellular carcinoma. Expert Opinion on Therapeutic Targets. 23(11). 915–929. 71 indexed citations
9.
Hussein, Hosni A. M., Usama M. Abdel-Raouf, & Shaw M. Akula. (2017). Membrane-Associated Kaposi Sarcoma-Associated Herpesvirus Glycoprotein B Promotes Cell Adhesion and Inhibits Migration of Cells via Upregulating IL-1β and TNF-α. Intervirology. 60(6). 217–226. 3 indexed citations
10.
Hussein, Hosni A. M. & Shaw M. Akula. (2017). miRNA-36 inhibits KSHV, EBV, HSV-2 infection of cells via stifling expression of interferon induced transmembrane protein 1 (IFITM1). Scientific Reports. 7(1). 17972–17972. 23 indexed citations
11.
Hussein, Hosni A. M., Lia R. Walker, & Shaw M. Akula. (2016). KSHV gB associated RGD interactions promote attachment of cells by inhibiting the potential migratory signals induced by the disintegrin-like domain. BMC Cancer. 16(1). 148–148. 4 indexed citations
12.
Hussein, Hosni A. M., et al.. (2015). Beyond RGD: virus interactions with integrins. Archives of Virology. 160(11). 2669–2681. 124 indexed citations
13.
Dyson, Ossie F., et al.. (2010). Cell Membrane-bound Kaposi's Sarcoma-associated Herpesvirus-encoded Glycoprotein B Promotes Virus Latency by Regulating Expression of Cellular Egr-1. Journal of Biological Chemistry. 285(48). 37491–37502. 26 indexed citations
14.
Akula, Shaw M., et al.. (2004). Raf promotes human herpesvirus-8 (HHV-8/KSHV) infection. Oncogene. 23(30). 5227–5241. 32 indexed citations
15.
16.
Akula, Shaw M., et al.. (2003). Kaposi's Sarcoma-Associated Herpesvirus (Human Herpesvirus 8) Infection of Human Fibroblast Cells Occurs through Endocytosis. Journal of Virology. 77(14). 7978–7990. 157 indexed citations
17.
Wang, Fuzhang, Shaw M. Akula, Neelam Sharma-Walia, Ling Zeng, & Bala Chandran. (2003). Human Herpesvirus 8 Envelope Glycoprotein B Mediates Cell Adhesion via Its RGD Sequence. Journal of Virology. 77(5). 3131–3147. 102 indexed citations
18.
19.
Akula, Shaw M., Fuzhang Wang, Jeffrey Vieira, & Bala Chandran. (2001). Human Herpesvirus 8 Interaction with Target Cells Involves Heparan Sulfate. Virology. 282(2). 245–255. 135 indexed citations
20.
Wang, Fuzhang, et al.. (2001). Human Herpesvirus 8 Envelope Glycoprotein K8.1A Interaction with the Target Cells Involves Heparan Sulfate. Journal of Virology. 75(16). 7517–7527. 121 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Fang Guo Breakdown of academic impact, for papers by Kei Kawana Breakdown of academic impact, for papers by Hua Peng Breakdown of academic impact, for papers by Subburaj Ilangumaran Breakdown of academic impact, for papers by Susanna Chiocca Breakdown of academic impact, for papers by Dieter Kube Breakdown of academic impact, for papers by Julio Gutiérrez Breakdown of academic impact, for papers by Gangqiao Zhou Breakdown of academic impact, for papers by Klaus Roemer Breakdown of academic impact, for papers by Bruno Sáinz
Rankless by CCL
2026